TDP-43 is increasingly seen as a potential therapeutic target in ALS, but its biology is complex,3 involving the regulation of thousands of human genes, with normal activity not physically confined to the nucleus. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.